United States · Venture startup

Who invested in Enable Injections

5 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$102Mraised across 5 rounds since 2011, from 5 sources

$2.0MVenture$30MSeries A$40MSeries B$30MVenture
Latest round
Venture, $30MJan 2026
Biggest round
$40MSeries B · Oct 2018
Investors
6
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20112013201520172019202120232025
?Seed$2.0MVenture$30MSeries A$40MSeries B$30MVenture
First round
Seed
Jan 2011
Biggest round
$40M
Series B · Oct 2018
Usual gap between rounds
3.8 years
the median of 4

The rounds

  1. Jan 2026
    Venture$30M3 new

    Source recordedSEC filing: $30M sold, first sale Dec 2025

  2. Oct 2018
    Series B$40M1 new

    Reported by BizjournalsSEC filing: $31M sold, first sale Oct 2018

  3. Oct 2016
    Series A$30M1 new

    Reported by FinSMEsSEC filing: $10M sold, first sale Aug 2016

  4. Sept 2014
    Venture$2.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $2.0M sold, first sale Sept 2014

  5. Jan 2011
    SeedAmount undisclosed1 new

    From a historical funding record

Founders and team

From Enable Injections's own website: 1 founder, 8 on the team.

Rick J. D'AugustineFounding Board member, Ethicon EndoSurgery, Enable
  • Matt HuddlestonExecutive Vice President and Chief Commercial Officer
  • Tim FlahertyExecutive Vice President and Chief Financial Officer
  • Eileen RogersSenior Vice President, Expansion Strategy and Medical Education
  • Mark RamserAssociate Vice President of Quality and Regulatory
  • Mehul DesaiSenior Vice President, Global Medical Affairs & Advocacy
  • Tiffany KhodadadSenior Vice President, Human Resources and Strategic Growth
  • Mike HoovenPresident and CEO
  • David KroekelChief Operating Officer

AdvisersDonald Rindell

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2011Venture2014Series A2016Series B2018Venture2026CincyTechSanofiFUSESanofi VenturesPartisan Management GroupORI Healthcare Fund

Everyone who backed them

CincyTechVC firm1round
SanofiInvestment firm1round
FUSEVC firm1round
Sanofi VenturesCorporate VC1round
ORI Healthcare FundGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Enable Injections as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Lightship CapitalVC firmPer its own site

Quick answers about Enable Injections

Who invested in Enable Injections?

Enable Injections's investors include CincyTech, Sanofi, FUSE, Sanofi Ventures and Partisan Management Group, and 1 more on record.

How much has Enable Injections raised?

Enable Injections has raised $102M across 5 rounds since 2011. One round did not disclose an amount, so the total is a floor.

When did Enable Injections last raise?

Enable Injections's most recent round was a Venture of $30M in Jan 2026.

What was Enable Injections's biggest round?

Enable Injections's largest round on record is $40M (Series B), in Oct 2018.

Who backed Enable Injections first?

Enable Injections's first round on record, in Jan 2011, was backed by Partisan Management Group.

What stage is Enable Injections at?

Enable Injections's latest named round is a Venture, in Jan 2026.

Where is Enable Injections based?

Enable Injections is based in the United States.

Companies like Enable Injections

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.